These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17204398)

  • 1. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia.
    Reddy R; Keshavan M; Yao JK
    Schizophr Res; 2007 Feb; 90(1-3):81-5. PubMed ID: 17204398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis.
    Reddy RD; Keshavan MS; Yao JK
    Clin Biochem; 2007 Sep; 40(13-14):1081-3. PubMed ID: 17601524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia.
    Yao JK; Magan S; Sonel AF; Gurklis JA; Sanders R; Reddy RD
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):171-6. PubMed ID: 15253886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses.
    Whalley LJ; Reading HW; Rosie R
    Psychol Med; 1984 Feb; 14(1):207-11. PubMed ID: 6143339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia.
    Yao JK; van Kammen DP; Moss HB; Sokulski DE
    Psychiatry Res; 1996 Jul; 63(2-3):123-32. PubMed ID: 8878308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis.
    Marcinko D; Pivac N; Martinac M; Jakovljević M; Mihaljević-Peles A; Muck-Seler D
    Psychiatry Res; 2007 Feb; 150(1):105-8. PubMed ID: 17270280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.
    Boullin DJ; Woods HF; Grimes RP; Grahame-Smith DG
    Br J Clin Pharmacol; 1975 Feb; 2(1):29-35. PubMed ID: 791316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
    Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changes of aggregability of blood platelets in schizophrenia.
    Dietrich-Muszalska A; Olas B
    World J Biol Psychiatry; 2009; 10(2):171-6. PubMed ID: 19514099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
    McAdams C; Leonard BE
    Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.
    Takano S; Suzuki T
    Fukushima J Med Sci; 1978 Feb; 25(1-2):1-7. PubMed ID: 748135
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.
    McBride PA; Anderson GM; Hertzig ME; Sweeney JA; Kream J; Cohen DJ; Mann JJ
    Arch Gen Psychiatry; 1989 Mar; 46(3):213-21. PubMed ID: 2919950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.
    Orr MW; Knox JM; Allen R; Gelder MG; Grahame-Smith DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):255-9. PubMed ID: 6111333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.